CN CULTURE GP (00745): Received a total of 75,628,000 shares of rights shares in total from 11 valid accepts.
The Chinese National Cultural Industry (00745) issued a notice on the record date stating that there are no ineligible shareholders, therefore there is no...
CN CULTURE GP (00745) announces that as of the record date, there are no disqualified shareholders, therefore there are no unsold shares for subscription by disqualified shareholders. As of February 27, 2025 (Thursday) at 4:00 pm (the final deadline), a total of 75,628,000 shares have been subscribed for (equivalent to approximately 48.4% of the total number of shares offered for subscription under the rights issue) in a total of 11 valid acceptances. The remaining 80,613,000 shares of unsold shares for subscription (equivalent to approximately 51.6% of the total number of shares offered for subscription under the rights issue) will be subject to the compensation arrangement.
Related Articles

HK Stock Market Move | Bitcoin rises above $93,000 LINEKONG (08267) up more than 22% OKG TECH (01499) up more than 17%

HK Stock Market Move | BILIBILI-W(09626) rose by more than 5%, Meta's acquisition of Manus will motivate the AI team to go global. Institutions say the value of AI applications in vertical industries should be taken seriously.

HK Stock Market Move | HENLIUS (02696) is currently up nearly 9%. The company's three innovative solid tumor drugs have been accepted for IND at the same time.
HK Stock Market Move | Bitcoin rises above $93,000 LINEKONG (08267) up more than 22% OKG TECH (01499) up more than 17%

HK Stock Market Move | BILIBILI-W(09626) rose by more than 5%, Meta's acquisition of Manus will motivate the AI team to go global. Institutions say the value of AI applications in vertical industries should be taken seriously.

HK Stock Market Move | HENLIUS (02696) is currently up nearly 9%. The company's three innovative solid tumor drugs have been accepted for IND at the same time.

RECOMMEND

Hong Kong Listed Companies’ Return To A Shares Heats Up As New “H To Shenzhen A” Case Emerges
05/01/2026

What Do The Top Ten Biopharma IPOs Of 2025 Tell Us?
05/01/2026

Asia’s Stock Markets Deliver A Strong 2025: Korea Soars 76%, Japan Tops Bubble‑Era Peak, Indonesia Records Best Year In 11 Years
05/01/2026


